Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
460.48
394.00
338.44
302.66
287.22
301.66
232.09
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
460.48
394.00
338.44
302.66
287.22
301.66
232.09
Raw Material Cost
179.53
155.46
138.78
124.99
117.99
129.89
89.15
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
115.29
100.17
80.20
75.89
71.23
65.29
62.47
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.25
3.67
5.75
5.48
2.94
2.68
2.32
Selling and Distribution Expenses
172.58
148.67
120.98
106.59
92.71
90.72
82.59
Other Expenses
-11.85
-10.38
-8.59
-8.14
-7.42
-6.80
-6.48
Total Expenditure (Excl Depreciation)
352.11
304.12
259.76
231.58
210.70
220.60
171.74
Operating Profit (PBDIT) excl Other Income
108.4
89.9
78.7
71.10000000000001
76.5
81.1
60.300000000000004
Other Income
-1.38
0.14
-1.04
-0.58
-3.11
-0.56
-0.27
Operating Profit (PBDIT)
126.97
105.86
89.56
81.12
82.97
89.35
68.76
Interest
3.25
3.67
5.75
5.48
2.94
2.68
2.32
Exceptional Items
0.00
0.00
-0.45
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
280.96
238.55
199.66
177.68
169.23
171.77
142.94
Depreciation
19.98
15.84
11.93
10.62
9.57
8.86
8.69
Profit Before Tax
103.74
86.35
71.44
65.02
70.46
77.81
57.76
Tax
6.73
6.50
5.61
5.57
4.18
5.00
3.71
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
97.01
79.85
65.83
59.45
66.28
72.81
54.05
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
97.01
79.85
65.83
59.45
66.28
72.81
54.05
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-0.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
97.01
79.85
65.83
59.45
66.28
72.81
54.04
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
416.24
368.21
306.40
280.27
267.08
252.43
217.37
Earnings per share (EPS)
4.85
3.99
3.29
2.97
3.31
3.64
2.7
Diluted Earnings per share
4.85
3.99
3.29
2.97
3.31
3.64
2.7
Operating Profit Margin (Excl OI)
23.54%
22.81%
23.25%
23.49%
26.64%
26.87%
26.0%
Gross Profit Margin
26.87%
25.94%
24.63%
24.99%
27.86%
28.73%
28.63%
PAT Margin
21.07%
20.27%
19.45%
19.64%
23.08%
24.14%
23.29%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 16.88% vs 16.43% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 21.55% vs 21.28% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 21.48% vs 16.67% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -10.81% vs -35.09% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Middle East Pharmaceutical Industries Co. With
Figures in Million
Consolidate Annual Results
Change(SAR)
Change(%)
Net Sales
460.48
0
460.48
Other Operating Income
0.00
0.00
0.00
Total Operating income
460.48
0
460.48
Raw Material Cost
179.53
0
179.53
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
115.29
0
115.29
Power Cost
0
0
0.00
Manufacturing Expenses
3.25
0
3.25
Selling and Distribution Expenses
172.58
0
172.58
Other Expenses
-11.85
0.00
-11.85
Total Expenditure (Excl Depreciation)
352.11
0
352.11
Operating Profit (PBDIT) excl Other Income
108.38
0.00
108.38
Other Income
-1.38
0
-1.38
Operating Profit (PBDIT)
126.97
0
126.97
Interest
3.25
0
3.25
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
280.96
0
280.96
Depreciation
19.98
0
19.98
Profit Before Tax
103.74
0
103.74
Tax
6.73
0
6.73
Provisions and contingencies
0
0
0.00
Profit After Tax
97.01
0
97.01
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
97.01
0
97.01
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
97.01
0
97.01
Equity Capital
0
0
0.00
Face Value
10.00
0
0.00
Reserves
416.24
0
416.24
Earnings per share (EPS)
4.85
0
4.85
Diluted Earnings per share
4.85
0
4.85
Operating Profit Margin (Excl OI)
23.54%
0%
0.00
23.54%
Gross Profit Margin
26.87%
0%
0.00
26.87%
PAT Margin
21.07%
0%
0.00
21.07%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 46.05 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 16.88% vs 16.43% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 9.70 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 21.55% vs 21.28% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.84 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 21.48% vs 16.67% in Dec 2024
Annual - Interest
Interest 0.33 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -10.81% vs -35.09% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.54%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
